TCS Biosciences
Private Company
Total funding raised: $1.5M
Overview
TCS Biosciences is a long-established, revenue-generating supplier of essential biological reagents and diagnostic products. The company operates a diversified portfolio across diagnostics, food safety, and cell culture research, leveraging a supply chain for animal and human-derived materials. Its business model is based on manufacturing and distributing high-quality, standardized products to support laboratory testing and R&D workflows globally. While not a therapeutic developer, it occupies a critical niche as a provider of tools and raw materials for the broader life sciences industry.
Technology Platform
Integrated supply chain and manufacturing expertise for biologically sourced materials, including animal/human biospecimen processing, quality control microorganism production, and diagnostic component manufacturing (e.g., for Cryptosporidium/Giardia detection).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
TCS operates in a competitive landscape dominated by large, global life science suppliers (e.g., Thermo Fisher Scientific, Merck Millipore) and numerous specialized niche players. It differentiates through deep expertise in specific areas like animal blood products, UKHSA-endorsed QC organisms, and water pathogen detection, catering to customers seeking specialized, high-quality materials.